Q32 Bio Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.23

+0.46 (+5.25%)

As of Sep 28, 10:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +202.7% upside

Low Target $24.18

Average Target $27.94

High Target $39.76

Current Price $9.23

Current
$9.23

Target
$27.94

$24.18 $27.94 avg $39.76

Scenario Analysis

Bear Case

$24.18

162.0%

Low target

Base Case

$27.94

+202.7%

Avg target

Bull Case

$39.76

+330.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$23.57

-60.8% from high

52-Week Low

$1.79

+415.4% from low

Target vs 52W High

$27.94

+18.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%